Analysis of cytogenetic alterations in stage III serous ovarian adenocarcinoma reveals a heterogeneous group regarding survival, surgical outcome, and substage.
Genes Chromosomes Cancer. 2004 Aug;40(4):342-8. doi: 10.1002/gcc.20053.
Genes Chromosomes Cancer. 2004.
PMID: 15188458